Featured Suppliers:

Ads by Google

Pfizer Incorporated

Refined by:

Industry: Aerospace, Marine & Defense

News and Blogs

Total : 5 View more »

Pfizer To Pay Record $2.3 Billion Penalty

www.manufacturing.net | Sep 2, 2009

World’s largest drugmaker will pay a $2.3 billion civil penalty over unlawful prescription drug promotions -- the largest settlement ever paid for alleged violations of federal drug rules.

http://www.manufacturing.net/News-Pfizer-To-Pay-Record-2B-Penalty-090209.aspx

Consumer memo: Wal-Mart announces Black Friday plan; Delta goes cashless; IBM s mobile software; free concerts online; Pfizer flap

www.kansascity.com | Nov 12, 2009

Wal-Mart Stores Inc. said Wednesday it will keep its stores open 24 hours and take new crowd-control measures Thanksgiving weekend after a temporary employee was trampled to death in a Black Friday rush last year.

http://www.kansascity.com/business/story/1564219.html

As airline industry's woes mount, unions ask administration's hel...

www.courant.com | Nov 12, 2009

WASHINGTON (AP) Three decades of airline deregulation have helped make air travel more accessible to consumers through lower fares.

http://www.courant.com/business/nationworld/wire/sns-ap-us-fixing-airlines,0,7475121.story

Earnings highlights: Boeing, Coca-Cola, eBay, Microsoft, Pfizer, ...

www.bloggingstocks.com | Oct 24, 2009

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password. To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you.

http://www.bloggingstocks.com/2009/10/24/earnings-highlights-boeing-coca-cola-ebay-microsoft-pfizer/

News from Zibb.com

Total : 284 View more »

AUDIO from Medialink and Pfizer Inc.: Reduce Holiday Stress to Help Ease Fibromyalgia - Zibb.com

NEW YORK, Nov 23, 2009 /PRNewswire via COMTEX/ --

Living with chronic pain can be difficult - and the stress of the holiday season can prove to be quite challenging for those living with pain.

Listen to this report from Pfizer Inc. at:

http://inr.mediaseed.tv/oneClip_C/?feed=Oww4_ZPSvfNn9C8Uw34nRje8SV0uFC3v

Medialink is a division of The NewsMarket. Registered journalists can access video, audio, text, graphics and photos at http://www.thenewsmarket.com.

11NY09-0660

SOURCE Medialink; Pfizer Inc.

http://www.thenewsmarket.com

Tags: graphics video

Companies: Pfizer, Inc. (PFE)

Permalink

Pfizer acquires stem cell therapies assets of Axordia - Zibb.com

Nov 23, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --

Pfizer, Ltd., a pharmaceutical company, has acquired certain assets related to stem cell therapies from Axordia Limited, a developer of stem cell therapies for human diseases, for a cash consideration of $0.75 million. Both the companies are based in the UK.

Deal Value (US$ Million) 0.75
Deal Type                Acquisition
Sub-Category             Asset Purchase
Deal Status              Completed: 2009-11-23

Deal Participants

Target (Company)   Axordia Limited - Stem Cell Therapies Assets
Acquirer (Company) Pfizer, Ltd. (UK)
Vendor (Company)   Axordia Limited

Tags: acquisition pharmaceuticals

Companies: Pfizer Ltd (PZRLF)

Permalink

Immunovaccine licenses vaccine platform to Pfizer Animal Health - Zibb.com

Nov 23, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --

ImmunoVaccine, Inc. (formerly Rhino Resources, Inc.), a Canadian vaccine development company, has signed an exclusive, worldwide licensing agreement with Pfizer Animal Health (PAH) for Immunovaccine's patented vaccine delivery technology. PAH is a US-based developer of vaccines and prescription medicines.

Under the terms of the agreement, Immunovaccine will receive upfront signing fees in addition to subsequent milestone payments and royalties on any Immunovaccine-delivered vaccines developed by PAH. PAH plans to develop enhanced cattle vaccines incorporating Immunovaccine's technology.

PAH is currently also licensing other Immunovaccine technology for the development of particular livestock vaccines.

Deal Type    Partnership
Sub-Category Acquisition of Rights
Deal Status  Announced: 2009-11-23

Deal Participants

Partner 1 (Company) Pfizer Animal Health
Partner 2 (Company) Pfizer, Inc.
Partner 3 (Company) ImmunoVaccine, Inc. (formerly Rhino Resources, Inc.)

Companies: Immunovaccine Inc (IMMVF), Rhino Resources Inc (RHI/P)

Permalink

Analyst Choice Initiates Research on Pfizer Inc., Ryland Group Inc., Domtar Corporation, Camden

NEW DELHI, INDIA, Nov 23, 2009 (MARKETWIRE via COMTEX) --

Despite weak dollar, US stocks traded in the red since the morning at Wall Street on Thursday, 19 November, 2009. But during the middle of the day, the dollar index pared some losses and started trading up. The consumer staples sector tried utmost to support the market though. This drove us to do research on the following 6 stocks Pfizer Inc. (NYSE: PFE), Ryland Group Inc. (NYSE: RYL), Domtar Corporation (NYSE: UFS), Camden Property Trust (NYSE: CPT), AXA (NYSE: AXA) and Ferro Corp. (NYSE: FOE). You can now access these research reports with many others by signing up at Analyst Choice.

To see if our analysts believe you should BUY, SELL or HOLD these six stocks sign up at Analyst Choice.

The following are exempts of the above reports:

--  We are pleased with the company's results this quarter and...

--  We feel good about company's position as we head into the end of the
    year and...

--  UFS is looking strong on the charts.

--  We are pleased that Camden's third quarter operating results were
    better than expected.

--  AXA's line trends for the first nine months are in line with the ones
    observed in the first half of 2009, with a modest revenue drop and...

--  FOE's positive momentum accelerated in the third quarter resulting in
    improved gross margins and...

You can now access these full research reports along with many others by signing up for free at Analyst Choice or www.analystchoice.com.

About Analyst Choice:

Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. While the world economy undergoes enormous pressure and unprecedented actions are been taken to avoid the worst and boost the shrinking global economic growth, our analysts brings you a bird's eye view of how the big players in the different key sectors and industries of the NASDAQ and NYSE, are coping. Sign up now by visiting the following link.

http://www.analystchoice.com/

AnalystChoice.com is an independent financial research portal and as such has not received any compensation by any of the above mentioned companies.

SOURCE: Analyst Choice

Companies: AXA (AXA), Camden Property Trust (CPT), Domtar, Inc. (DTC), Ferro Corp. (FOE), Pfizer, Inc. (PFE), Ryland Group, Inc. (The) (RYL), U.S. Foodservice (UFS)

Permalink

Web Sites

Total : 172 View more »

[video] Foreign Fix for Airlines? (at CNBC)

www.cnbc.com

Skip navigation REAL-TIME QUOTES FREE Real-Time Quotes for EXTENDED HOURS now available from the NYSE and the NASDAQ close message FREE Real-Time Quotes for EXTENDED HOURS now available from the NYSE and the NASDAQ Quote | Chart Symbol Lookup All CNBC | News | Video Ad Ad Register Sign In Member

http://www.cnbc.com/id/15840232?play=1&video=762572425&__source=yahoo|headline|quote|video|&par=yahoo

Leaving Pfizer.com | Pfizer: the world's largest research-based pharmaceutical company

You are now leaving www.pfizer.com. Links to sites outside of Pfizer are provided as a resource to the viewer. Pfizer accepts no responsibility for the content of linked sites.

http://www.pfizer.com/general/jump.jsp?url=http://www.truste.org/consumers/watchdog_complaint.php&display=TRUSTe%20Privacy%20Program